Naga Sai Rasagna Mareddy

Naga Sai Rasagna Mareddy

Auto-generated profile, based on publicly available information

Naga Sai Rasagna Mareddy

Department of Radiology, University of Alabama at Birmingham, Birmingham, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
PDPaula Dibo
Paula Dibo
NMNaga Sai Rasagna Mareddy
Naga Sai Rasagna Mareddy
GKGiovana Schlichta Adriano Kojima
Giovana Schlichta Adriano Kojima
MEMohamad Ershed
Mohamad Ershed
OOOgechukwu Samuel Obi
Ogechukwu Samuel Obi
VKVineeta Kumar
Vineeta Kumar
In patients with chronic kidney disease, mineralocorticoid receptor antagonists (MRAs) exert a reno-protective effect through its anti-inflammatory and antifibrotic effects. Less is known about the efficacy of MRAs in kidney transplant (KT) recipients. This meta-analysis aims to systematically assess the efficacy of MRAs in KT recipients. PubMed, Embase and Cochrane databases were searched for randomized controlled trials (RCTs) that compared MRAs to placebo in KT recipients and reported the outcomes of (1) glomerular filtration rate (GFR); (2) serum creatinine; (3) systolic (SBP) and diastolic blood pressure (DBP); (4) hyperkalemia; and (5) interstitial fibrosis and tubular atrophy (IFTA) scores. Heterogeneity was examined with I2 statistics. A random-effects model was used for outcomes with high heterogeneity. We included 5 RCTs with 293 patients, of whom 142 (48.5%) underwent treatment with a steroidal MRA. Mean follow-up ranged from 5 days to 36 months. There was no significant difference in GFR (MD 9.04 mL/min/1.73 m2; 95% CI − 2.76–20.85; p = 0.13) and serum creatinine between placebo and MRA groups (MD − 0.21 mg/dL; 95% CI − 0.62–0.20; p = 0.32). SBP (MD 0.69 mmHg; 95% CI − 0.69–2.08; p = 0.33), DBP (MD 0.45 mmHg; 95% CI − 0.69–1.59; p = 0.44) and IFTA scores exhibited no differences between groups (mild IFTA RR 1.21; 95% 0.83–1.74; p = 0.32) (moderate IFTA RR 0.82; 95% CI 0.45–1.50; P = 0.51) (severe IFTA RR 0.64; 95% CI 0.24–1.76; p = 0.39). MRAs were associated with a 4-fold increase in the risk of hyperkalemia compared with placebo (RR 4.06; 95% CI 1.46–11.28; p = 0.007). Steroidal MRAs have no superior efficacy compared with placebo in KT recipients and are associated with a 4-fold increase in the risk of hyperkalemia despite preserved kidney function. Not applicable.

12 September 2024 in Academic Medicine & Surgery
Verified
Journal Article
Open access
PDF file
IGInayat Grewal
Inayat Grewal
HSHamza A Salim
Hamza A Salim
AZAroosa Zamarud
Aroosa Zamarud
NMNaga Sai Rasagna Mareddy
Naga Sai Rasagna Mareddy
PMPrateek Madaan
Prateek Madaan
KAKaran Aggarwal
Karan Aggarwal
The COVID-19 pandemic significantly disrupted radiology education, leading to a rapid transition from traditional in-person instruction to online learning. This article reviews the innovative digital tools and strategies adopted during this period, such as microlearning, virtual reality, and tablet apps, which were central in maintaining educational quality. While online platforms offered flexibility, accessibility, and global reach, challenges such as the lack of personal interaction and variability in resource quality persisted. The article emphasizes the importance of balancing online and in-person learning and highlights future directions in radiology education, including the integration of Artificial Intelligence (AI) and Virtual Reality (VR) to enhance training. By leveraging these advancements, radiology education can continue to evolve, offering comprehensive and adaptable learning experiences for trainees.